Connect with us

Business

Care By Design

Published

on

Care By Design Picture-2

Care By Design

CBD.org

 

How would you describe your company? What is your specialty?

Care By Design produces CBD-rich cannabis therapeutics.

What do you offer consumers/clients that others don’t?

Care By Design makes products from the flowers and leaf of local, sustainably grown cannabis. We offer products in medically appropriate formulations, including sublingual sprays, smokeless vape cartridges, extracts and soft gel caps. Care By Design offers a full spectrum of CBD:THC ratios and strains so that patients can comfortably optimize their cannabinoid therapy while moderating psychoactive effects based on personal preferences. We maintain rigorous consistency (unit-to-unit) in the quantity of active ingredients by manufacturing all products in a PFC-certified lab. We ensure our products are lab-tested and free from contaminants. It is important to us to provide complete and accurate labeling. Care By Design is committed to maintaining full transparency from seed to shelf, we even aim to promote community safety by using non-flammable extraction methods in our processes.

How and why did your company start up?

We founded Care By Design to provide medical patients with reliably safe and effective cannabis medicines. In particular, our goal was to empower patients to calibrate dosing in a repeatable and reliable fashion for maximum benefit.

With the changing landscape of MMJ and recreational cannabis, what do you see as the biggest challenges to your progress as a company? Any advantages?

Currently, California state law requires we maintain a fully, vertically integrated, non-profit patient collective that takes responsibility for cultivation, extraction, production, distribution, transport and retail. The new state regulations require that many of these functions be done by independent entities. This will require a radical restructuring of the business operations. More importantly though, at each juncture—between cultivation and extraction, extraction and retail—the product has to go through an independent distributor. There will be a very limited number of distributors. All of this combined is likely to dramatically increase the cost structure for producing medicinal cannabis products, which is going to hurt the patient.

That being said, in the current climate, there is always a risk of law enforcement action (including “summary eradication” of legal grows)—even for fully compliant, non-profit patient collectives. It will be a relief to not have this weighing on us.

What are the goals and visions moving forward for your company? Where do you see your company in five years?

We’re currently engaged in research on cannabis’ efficacy in a number of areas, including PTSD, cancer, autism, epilepsy and other conditions. Within five years, we expect to be producing more targeted formulations, and we expect to be able to provide better guidance on which cannabinoid profiles are most appropriate for which medical conditions.

What words of advice would you offer anyone seeking to enter the world of cannabis business? More specifically . . . what is unique to this type of work or this industry, in your opinion?

Get comfortable with change! It’s a rapidly changing and growing industry. And, that’s unlikely to change in the foreseeable future.

What do you hope to accomplish in the MMJ industry?

We hope to play a role in bringing cannabis out of the shadows and re-establishing it as a safe, effective and readily accessible herbal remedy.

Any sneak peeks on new products or news you’d like to share?

We have a line of topicals and edibles coming out before the end of the year—both of which have market-tested extremely well. We’re very excited. We’re also rolling out soft gel caps.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *